Exciting Innovations from Harvard Bioscience
Harvard Bioscience, Inc. (NASDAQ: HBIO) is gearing up to present a variety of groundbreaking products at an important annual gathering tailored for safety pharmacologists. The company is dedicated to advancing life sciences and has crafted solutions that meet the varied needs of researchers and developers in the pharmaceutical sector.
Product Highlights from the Annual Meeting
During the upcoming Safety Pharmacology Society (SPS) Annual Meeting, Harvard Bioscience will feature its innovative technological products designed to enhance preclinical research. The focus will be on their latest offerings, particularly designed to streamline research workflows and boost data management efficiency.
DSI™ Ponemah™ Data Management Platform
The Ponemah™ platform is an integrated preclinical solution that excels in managing and analyzing extensive datasets from a variety of studies. It complies with GLP standards, which has earned it recognition for its solid capabilities. The platform works flawlessly with DSI’s SoHo™ implantable telemetry, enabling researchers to efficiently gather and analyze in-vivo data while also embracing new in-vitro methods. Thanks to its use of machine learning algorithms, the Ponemah platform facilitates the sophisticated analysis of large data sets.
SoHo™ Implantable Telemetry System
The SoHo telemetry system has rapidly become indispensable for preclinical researchers. This device is engineered to accommodate multiple small animal models, allowing studies to be conducted in shared housing environments. Its compact design minimizes disruption to natural behaviors during testing. Moreover, the system features improved power management that supports longer studies, thereby enhancing the overall effectiveness of research protocols.
Advanced Activity Monitoring with VivaMARS™
VivaMARS™ Activity Monitoring System is recognized for its high-throughput capabilities, providing real-time behavioral testing in neuropharmacology and toxicology studies. When integrated with the Ponemah platform, it creates a comprehensive and compliant testing environment. This combination greatly benefits Contract Research Organizations (CROs) and pharmaceutical companies, making longitudinal studies more cost-effective and quicker.
MCS™ Mesh MEA™ Organoid Platform
Another highlight from Harvard Bioscience is the MCS™ Mesh MEA™ Organoid platform. This innovative technology allows researchers to take accurate electrophysiological measurements within live organoid environments. It shows particular promise for studies focused on neurological and cardiac functions, proving to be an essential tool in safety pharmacology and toxicology research. Currently undergoing evaluations at several test sites, the Mesh MEA platform is on track for full production soon, improving access for researchers globally.
Commitment to Therapy Development
Jim Green, Chairman and CEO of Harvard Bioscience, states that the innovations on display at this year’s SPS Conference underscore the company's commitment to leading in wireless telemetry. The SoHo implants reflect their dedication to enhancing technology in both academic fields and industrial applications. Data presentations highlighting collaborations with top customers will also be featured during the conference.
Exhibition and Engagement at SPS
Harvard Bioscience will be showcasing its top-notch solutions at booth 501 during the Safety Pharmacology Society Annual Meeting. This gathering provides a great opportunity for dialogue, allowing experts to discuss their pioneering innovations and receive feedback from peers in the field. The exhibit will take place from the 23rd to the 24th, and Harvard Bioscience encourages all attendees to connect with their representatives.
About Harvard Bioscience
Harvard Bioscience, Inc. specializes in developing technologies that are crucial for progress in life sciences. The company supports not just academic institutions but also the global pharmaceutical and biotechnology industries, covering North America, Europe, and Asia. This extensive reach solidifies its position as a key player in life science applications, offering products and services tailored to a wide range of research needs and boosting productivity and innovation in the field.
Frequently Asked Questions
What will Harvard Bioscience showcase at the SPS Annual Meeting?
They will display innovative products including the Ponemah™ platform, SoHo™ telemetry system, and VivaMARS™ monitoring system.
How does the Ponemah™ platform assist researchers?
The Ponemah platform integrates various data collection systems, allowing for the management and analysis of extensive preclinical study data.
What are the benefits of the SoHo™ telemetry system?
The SoHo system enables real-time monitoring of animal models and supports longitudinal studies with reduced spatial requirements.
What are the applications of the Mesh MEA™ platform?
This platform is used for electrophysiological measurements in organoid research, particularly for neurological and cardiac studies.
How can researchers learn more about Harvard Bioscience's products?
Researchers can visit the Harvard Bioscience website or engage with their representatives at industry events for detailed information.
